On the Board

Some 40 percent of the largest pharmaceutical companies have at least one board member on their board of directors who is also in a leadership position at an academic medical center, researchers led by Walid Gellad from the VA Pittsburgh Healthcare System and his colleagues report in the Journal of the American Medical Association this week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.